Cargando…

An EAACI task force report: recognising the potential of the primary care physician in the diagnosis and management of drug hypersensitivity

Adverse drug reactions include drug hypersensitivity reactions (DHRs), which can be immunologically mediated (allergy) or non-immunologically mediated. The high number of DHRs that are unconfirmed and often self-reported is a frequent problem in daily clinical practice, with considerable impact on f...

Descripción completa

Detalles Bibliográficos
Autores principales: Doña, I., Caubet, J. C., Brockow, K., Doyle, M., Moreno, E., Terreehorst, I., Torres, M. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5944153/
https://www.ncbi.nlm.nih.gov/pubmed/29760877
http://dx.doi.org/10.1186/s13601-018-0202-2
_version_ 1783321773298679808
author Doña, I.
Caubet, J. C.
Brockow, K.
Doyle, M.
Moreno, E.
Terreehorst, I.
Torres, M. J.
author_facet Doña, I.
Caubet, J. C.
Brockow, K.
Doyle, M.
Moreno, E.
Terreehorst, I.
Torres, M. J.
author_sort Doña, I.
collection PubMed
description Adverse drug reactions include drug hypersensitivity reactions (DHRs), which can be immunologically mediated (allergy) or non-immunologically mediated. The high number of DHRs that are unconfirmed and often self-reported is a frequent problem in daily clinical practice, with considerable impact on future prescription choices and patient health. It is important to distinguish between hypersensitivity and non-hypersensitivity reactions by adopting a structured diagnostic approach to confirm or discard the suspected drug, not only to avoid life-threatening reactions, but also to reduce the frequent over-diagnosis of DHRs. Primary care physicians are often the first point of contact for the sufferer of a reaction, as such they have a key role in deciding whether to discard the diagnosis or send the patient for further investigation. In this review, we highlight the importance of diagnosing DHRs, analysing in detail the role of primary care physicians. We describe the common patterns of DHRs and signs of its progression, as well as the indications and contraindications for referring the patient to an allergist. The diagnostic process is described and the possible tests are discussed, which often depend on the drug involved and the type of DHR suspected. We also describe recommendations regarding the avoidance of medication suspected to have caused the reaction and the use of alternatives.
format Online
Article
Text
id pubmed-5944153
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-59441532018-05-14 An EAACI task force report: recognising the potential of the primary care physician in the diagnosis and management of drug hypersensitivity Doña, I. Caubet, J. C. Brockow, K. Doyle, M. Moreno, E. Terreehorst, I. Torres, M. J. Clin Transl Allergy Review Adverse drug reactions include drug hypersensitivity reactions (DHRs), which can be immunologically mediated (allergy) or non-immunologically mediated. The high number of DHRs that are unconfirmed and often self-reported is a frequent problem in daily clinical practice, with considerable impact on future prescription choices and patient health. It is important to distinguish between hypersensitivity and non-hypersensitivity reactions by adopting a structured diagnostic approach to confirm or discard the suspected drug, not only to avoid life-threatening reactions, but also to reduce the frequent over-diagnosis of DHRs. Primary care physicians are often the first point of contact for the sufferer of a reaction, as such they have a key role in deciding whether to discard the diagnosis or send the patient for further investigation. In this review, we highlight the importance of diagnosing DHRs, analysing in detail the role of primary care physicians. We describe the common patterns of DHRs and signs of its progression, as well as the indications and contraindications for referring the patient to an allergist. The diagnostic process is described and the possible tests are discussed, which often depend on the drug involved and the type of DHR suspected. We also describe recommendations regarding the avoidance of medication suspected to have caused the reaction and the use of alternatives. BioMed Central 2018-05-10 /pmc/articles/PMC5944153/ /pubmed/29760877 http://dx.doi.org/10.1186/s13601-018-0202-2 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Review
Doña, I.
Caubet, J. C.
Brockow, K.
Doyle, M.
Moreno, E.
Terreehorst, I.
Torres, M. J.
An EAACI task force report: recognising the potential of the primary care physician in the diagnosis and management of drug hypersensitivity
title An EAACI task force report: recognising the potential of the primary care physician in the diagnosis and management of drug hypersensitivity
title_full An EAACI task force report: recognising the potential of the primary care physician in the diagnosis and management of drug hypersensitivity
title_fullStr An EAACI task force report: recognising the potential of the primary care physician in the diagnosis and management of drug hypersensitivity
title_full_unstemmed An EAACI task force report: recognising the potential of the primary care physician in the diagnosis and management of drug hypersensitivity
title_short An EAACI task force report: recognising the potential of the primary care physician in the diagnosis and management of drug hypersensitivity
title_sort eaaci task force report: recognising the potential of the primary care physician in the diagnosis and management of drug hypersensitivity
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5944153/
https://www.ncbi.nlm.nih.gov/pubmed/29760877
http://dx.doi.org/10.1186/s13601-018-0202-2
work_keys_str_mv AT donai aneaacitaskforcereportrecognisingthepotentialoftheprimarycarephysicianinthediagnosisandmanagementofdrughypersensitivity
AT caubetjc aneaacitaskforcereportrecognisingthepotentialoftheprimarycarephysicianinthediagnosisandmanagementofdrughypersensitivity
AT brockowk aneaacitaskforcereportrecognisingthepotentialoftheprimarycarephysicianinthediagnosisandmanagementofdrughypersensitivity
AT doylem aneaacitaskforcereportrecognisingthepotentialoftheprimarycarephysicianinthediagnosisandmanagementofdrughypersensitivity
AT morenoe aneaacitaskforcereportrecognisingthepotentialoftheprimarycarephysicianinthediagnosisandmanagementofdrughypersensitivity
AT terreehorsti aneaacitaskforcereportrecognisingthepotentialoftheprimarycarephysicianinthediagnosisandmanagementofdrughypersensitivity
AT torresmj aneaacitaskforcereportrecognisingthepotentialoftheprimarycarephysicianinthediagnosisandmanagementofdrughypersensitivity
AT donai eaacitaskforcereportrecognisingthepotentialoftheprimarycarephysicianinthediagnosisandmanagementofdrughypersensitivity
AT caubetjc eaacitaskforcereportrecognisingthepotentialoftheprimarycarephysicianinthediagnosisandmanagementofdrughypersensitivity
AT brockowk eaacitaskforcereportrecognisingthepotentialoftheprimarycarephysicianinthediagnosisandmanagementofdrughypersensitivity
AT doylem eaacitaskforcereportrecognisingthepotentialoftheprimarycarephysicianinthediagnosisandmanagementofdrughypersensitivity
AT morenoe eaacitaskforcereportrecognisingthepotentialoftheprimarycarephysicianinthediagnosisandmanagementofdrughypersensitivity
AT terreehorsti eaacitaskforcereportrecognisingthepotentialoftheprimarycarephysicianinthediagnosisandmanagementofdrughypersensitivity
AT torresmj eaacitaskforcereportrecognisingthepotentialoftheprimarycarephysicianinthediagnosisandmanagementofdrughypersensitivity